Clinical Trials associated with GENEVAX (Hebei) Biotechnology Co., Ltd.
CTR20243418
/ Not yet recruitingPhase 1
评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群使用的安全性和免疫原性的Ⅰ期临床试验
[Translation] Phase I clinical trial to evaluate the safety and immunogenicity of a recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
评价重组带状疱疹疫苗在40周岁及以上人群中使用的安全性和免疫原性。
[Translation]
To evaluate the safety and immunogenicity of recombinant herpes zoster vaccine in people aged 40 years and above.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.